Target Name: RNA5SP463
NCBI ID: G100873707
Other Name(s): RNA, 5S ribosomal pseudogene 463 | RNA, 5S ribosomal 463 | RN5S463

RNA5SP463: A Potential Drug Target and Biomarker

RNA5SP463 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell's response to environmental stress, and its levels have been shown to be significantly decreased in various diseases, including cancer. RNA5SP463 has also been shown to have a positive correlation with the survival rate in cancer patients. This suggests that it may be a valuable biomarker for cancer diagnosis and treatment.

The Discovery of RNA5SP463

RNA5SP463 was first identified using RNA sequencing technology. The RNA sequencing data revealed that it was expressed in various tissues and cells, including the brain, heart, and liver. It was also found to be highly expressed in cancer tissues, which suggests that it may be involved in the development and progression of cancer.

The RNA5SP463 gene

The RNA5SP463 gene is located on chromosome 6 and encodes a non-coding RNA molecule of 21 amino acids. The RNA molecule has a characteristic structure that is composed of a stem-loop region and a terminal region. The stem-loop region is the most conserved part of the molecule and is responsible for the stability of the RNA molecule. The terminal region is the part of the molecule that interacts with other molecules and is involved in the regulation of the RNA molecule.

The Expression of RNA5SP463

RNA5SP463 is highly expressed in various tissues and cells in the body. It is found in the brain, heart, liver, and other organs, and its levels are typically higher in tissues that are under stress, such as cancer cells. RNA5SP463 has also been shown to be highly expressed in various types of cancer, including breast, lung, and ovarian cancer.

The Potential Role of RNA5SP463 as a Drug Target

RNA5SP463 has been shown to play a role in the regulation of cellular processes that are important for cancer development. It has been shown to be involved in the regulation of cell cycle progression, apoptosis (programmed cell death), and angiogenesis (the formation of new blood vessels). RNA5SP463 has also been shown to be involved in the regulation of inflammation, which is a key factor in cancer progression.

RNA5SP463 has also been shown to interact with several protein molecules that are involved in cancer development. These proteins include the oncogene PDGF-AA, the tumor suppressor TP53, and the signaling molecule NF-kappa-B. The interaction between RNA5SP463 and these proteins may be involved in the regulation of cellular processes that are important for cancer development.

The Potential Role of RNA5SP463 as a Biomarker

RNA5SP463 has also been shown to have a positive correlation with the survival rate in cancer patients. This suggests that it may be a valuable biomarker for cancer diagnosis and treatment. The levels of RNA5SP463 have also been shown to be significantly decreased in various diseases, including cancer. This suggests that it may be a useful target for new diagnostic or therapeutic strategies.

Conclusion

RNA5SP463 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its levels are typically higher in tissues that are under stress, such as cancer cells, and it has been shown to play a role in the regulation of cellular processes that are important for cancer development. RNA5SP463 has also been shown to have a positive correlation with the survival rate in cancer patients and may be a valuable biomarker for cancer diagnosis and treatment. Further research is needed to fully understand the role of RNA5SP463 in cancer biology and to develop new diagnostic or therapeutic strategies.

Protein Name: RNA, 5S Ribosomal Pseudogene 463

More Common Targets

RNA5SP464 | RNA5SP465 | RNA5SP479 | RNA5SP493 | RNA5SP496 | RNA5SP497 | RNA5SP505 | RNA5SP511 | RNA5SP518 | RNA5SP52 | RNA5SP53 | RNA5SP54 | RNA5SP57 | RNA5SP63 | RNA5SP85 | RNA5SP91 | RNASE1 | RNASE10 | RNASE11 | RNASE11-AS1 | RNASE12 | RNASE13 | RNASE2 | RNASE2CP | RNASE3 | RNASE4 | RNASE6 | RNASE7 | RNASE8 | RNASE9 | RNASEH1 | RNASEH1-DT | RNASEH2A | RNASEH2B | RNASEH2B-AS1 | RNASEH2C | RNASEH2CP1 | RNASEK | RNASEL | RNASET2 | RND1 | RND2 | RND3 | RNF10 | RNF103 | RNF103-CHMP3 | RNF11 | RNF111 | RNF112 | RNF113A | RNF113B | RNF114 | RNF115 | RNF121 | RNF122 | RNF123 | RNF125 | RNF126 | RNF126P1 | RNF128 | RNF13 | RNF130 | RNF133 | RNF135 | RNF138 | RNF138P1 | RNF139 | RNF139-DT | RNF14 | RNF141 | RNF144A | RNF144B | RNF145 | RNF146 | RNF148 | RNF149 | RNF150 | RNF151 | RNF152 | RNF157 | RNF157-AS1 | RNF165 | RNF166 | RNF167 | RNF168 | RNF169 | RNF17 | RNF170 | RNF175 | RNF180 | RNF181 | RNF182 | RNF183 | RNF185 | RNF186 | RNF187 | RNF19A | RNF19B | RNF2 | RNF20